Published in Science on October 31, 2008
Principles of cancer therapy: oncogene and non-oncogene addiction. Cell (2009) 10.96
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol (2009) 6.43
Identification of aneuploidy-selective antiproliferation compounds. Cell (2011) 4.45
Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer (2010) 3.95
Identification of aneuploidy-tolerating mutations. Cell (2010) 3.73
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature (2010) 3.72
Chromosomal instability confers intrinsic multidrug resistance. Cancer Res (2011) 3.70
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol (2010) 3.28
Aneuploidy drives genomic instability in yeast. Science (2011) 3.22
Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science (2013) 2.79
Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell (2009) 2.58
Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature (2014) 2.30
Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell (2011) 2.29
Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep (2012) 2.28
Gene balance hypothesis: connecting issues of dosage sensitivity across biological disciplines. Proc Natl Acad Sci U S A (2012) 2.20
Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet (2009) 2.07
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res (2011) 2.05
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03
The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci U S A (2010) 1.98
Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans. PLoS Biol (2013) 1.88
High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci U S A (2011) 1.86
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells. Nat Cell Biol (2014) 1.86
Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep (2012) 1.81
Gene copy-number alterations: a cost-benefit analysis. Cell (2013) 1.79
Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol Cell (2011) 1.77
Cohesin-SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres. EMBO J (2012) 1.73
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature (2010) 1.70
Transcriptional consequences of aneuploidy. Proc Natl Acad Sci U S A (2012) 1.70
Aneuploidy causes proteotoxic stress in yeast. Genes Dev (2012) 1.66
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies. PLoS Genet (2011) 1.65
Killing cells by targeting mitosis. Cell Death Differ (2012) 1.65
The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet (2011) 1.60
Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ (2010) 1.57
Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol (2012) 1.57
Aneuploidy-induced cellular stresses limit autophagic degradation. Genes Dev (2015) 1.54
PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell (2013) 1.52
Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep (2012) 1.51
Linking abnormal mitosis to the acquisition of DNA damage. J Cell Biol (2012) 1.48
Links between mutant p53 and genomic instability. J Cell Biochem (2012) 1.41
The role of aneuploidy in promoting and suppressing tumors. J Cell Biol (2009) 1.39
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects. Oncotarget (2016) 1.38
Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr Opin Cell Biol (2010) 1.38
Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.38
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis. BMC Cell Biol (2016) 1.37
New insights into the troubles of aneuploidy. Annu Rev Cell Dev Biol (2012) 1.36
Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Single cell sequencing reveals low levels of aneuploidy across mammalian tissues. Proc Natl Acad Sci U S A (2014) 1.34
Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet (2010) 1.32
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol (2014) 1.29
pRB, a tumor suppressor with a stabilizing presence. Trends Cell Biol (2011) 1.25
2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol (2013) 1.19
The aneuploidy paradox in cell growth and tumorigenesis. Cancer Cell (2008) 1.19
Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast. Elife (2014) 1.19
Aneuploidy: cancer's fatal flaw? Cancer Res (2009) 1.16
Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol Biol Cell (2013) 1.16
Aneuploidy and tumorigenesis. Semin Cell Dev Biol (2011) 1.15
Selective cell death of hyperploid neurons in Alzheimer's disease. Am J Pathol (2010) 1.15
Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein. J Biol Chem (2014) 1.14
Aneuploidy in health, disease, and aging. J Cell Biol (2013) 1.13
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div (2015) 1.07
Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy. Genome Biol (2011) 1.07
Unique features of the transcriptional response to model aneuploidy in human cells. BMC Genomics (2014) 1.06
BRAF inactivation drives aneuploidy by deregulating CRAF. Cancer Res (2010) 1.05
Constitutional aneuploidy and cancer predisposition. Hum Mol Genet (2009) 1.05
The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin Cell Dev Biol (2013) 1.05
Dancing genomes: fungal nuclear positioning. Nat Rev Microbiol (2009) 1.04
Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLoS One (2011) 1.03
Widespread transcriptional autosomal dosage compensation in Drosophila correlates with gene expression level. Genome Biol Evol (2009) 1.03
Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group. J Cell Mol Med (2009) 1.03
Cancer cells preferentially lose small chromosomes. Int J Cancer (2012) 1.02
Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2. Genes Cancer (2012) 1.02
Cancer. Aneuploidy drives a mutator phenotype in cancer. Science (2011) 1.01
Mechanisms of aneuploidy. Curr Opin Cell Biol (2011) 1.01
Chromosome-specific accumulation of aneuploidy in the aging mouse brain. Hum Mol Genet (2012) 1.00
Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer (2011) 1.00
Aneuploidy: implications for protein homeostasis and disease. Dis Model Mech (2014) 1.00
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. Front Oncol (2014) 1.00
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice. Nat Commun (2016) 1.00
Adaptive downregulation of mitochondrial function in down syndrome. Cell Metab (2013) 1.00
A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. Cancer Res (2013) 0.98
HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells. EMBO J (2014) 0.98
Aneuploidy and drug resistance in pathogenic fungi. PLoS Pathog (2012) 0.98
Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med (2011) 0.97
Aneuploidy and improved growth are coincident but not causal in a yeast cancer model. PLoS Biol (2009) 0.97
How do human cells react to the absence of mitochondrial DNA? PLoS One (2009) 0.97
Genomic instability and colon carcinogenesis: from the perspective of genes. Front Oncol (2013) 0.97
Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS One (2011) 0.96
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells. Cell Cycle (2015) 0.96
The presence of extra chromosomes leads to genomic instability. Nat Commun (2016) 0.95
BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). Cell Death Differ (2010) 0.95
Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo. Oncogene (2011) 0.95
Slow proliferation as a biological feature of colorectal cancer metastasis. Br J Cancer (2009) 0.94
Centromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas. Carcinogenesis (2011) 0.93
Whole chromosome aneuploidy: big mutations drive adaptation by phenotypic leap. Bioessays (2012) 0.93
The fitness consequences of aneuploidy are driven by condition-dependent gene effects. PLoS Biol (2015) 0.93
Chromosome missegregation causes colon cancer by APC loss of heterozygosity. Cell Cycle (2010) 0.92
Epigenetic and developmental regulation in plant polyploids. Curr Opin Plant Biol (2015) 0.90
Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution. PLoS One (2013) 0.90
Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol (1963) 29.15
Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics (1972) 22.68
A Cytological and Genetical Study of Triploid Maize. Genetics (1929) 10.35
Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science (2007) 7.69
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet (2004) 6.85
Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell (2006) 6.37
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell (2006) 5.88
Energy metabolism in tumor cells. FEBS J (2007) 5.16
Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science (2006) 4.09
Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet (2000) 3.84
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
A switch from high-fidelity to error-prone DNA double-strand break repair underlies stress-induced mutation. Mol Cell (2005) 2.88
Recombination between short DNA homologies causes tandem duplication. Nature (1981) 2.85
Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature (2008) 2.71
The bases of the locomotory behaviour of fibroblasts. Exp Cell Res (1961) 2.49
Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics (2003) 2.19
Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12
Clonal adaptation during carcinogenesis. Biochem Pharmacol (1990) 2.04
Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. J Cell Physiol (1974) 1.96
Growth arrest and chromosome instability in aneuploid yeast. Yeast (2006) 1.60
Roles of YqjH and YqjW, homologs of the Escherichia coli UmuC/DinB or Y superfamily of DNA polymerases, in stationary-phase mutagenesis and UV-induced mutagenesis of Bacillus subtilis. J Bacteriol (2003) 1.45
Systematic approach to the study of trisomy in the mouse. II. Cytogenet Cell Genet (1975) 1.40
A tumor profile in Down syndrome. Am J Med Genet (1998) 1.26
Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol (2006) 1.19
Secondary trisomics and telotrisomics of rice: origin, characterization, and use in determining the orientation of chromosome map. Genetics (1996) 1.16
Assessments of clonal composition of colorectal adenomas by FISH analysis of chromosomes 1, 7, 13 and 20. Int J Cancer (2001) 1.07
Murine trisomy: developmental profiles of the embryo, and isolation of trisomic cellular systems. J Exp Zool (1983) 1.03
Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer Genet Cytogenet (1998) 1.00
Are solid tumours different in children with Down's syndrome? Int J Cancer (2003) 0.96
In vitro growth kinetics of mouse trisomies 12 and 19. Hereditas (1985) 0.90
Cell cycle and cell size regulation in Down syndrome cells. J Neural Transm Suppl (2003) 0.90
Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science (2007) 7.69
The genome of the sea urchin Strongylocentrotus purpuratus. Science (2006) 6.41
Identification of aneuploidy-selective antiproliferation compounds. Cell (2011) 4.45
Closing mitosis: the functions of the Cdc14 phosphatase and its regulation. Annu Rev Genet (2004) 4.18
Separase, polo kinase, the kinetochore protein Slk19, and Spo12 function in a network that controls Cdc14 localization during early anaphase. Cell (2002) 4.16
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Identification of aneuploidy-tolerating mutations. Cell (2010) 3.73
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev (2010) 3.56
Aneuploidy: cells losing their balance. Genetics (2008) 3.48
Suppression of lung adenocarcinoma progression by Nkx2-1. Nature (2011) 3.27
Aneuploidy drives genomic instability in yeast. Science (2011) 3.22
Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell (2012) 3.20
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med (2004) 3.03
Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature (2010) 3.03
Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature (2004) 2.90
Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. Science (2013) 2.79
Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci U S A (2003) 2.77
A genome-wide screen identifies genes required for centromeric cohesion. Science (2004) 2.60
Meiosis: cell-cycle controls shuffle and deal. Nat Rev Mol Cell Biol (2004) 2.53
mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci U S A (2008) 2.50
Role of Polo-like kinase CDC5 in programming meiosis I chromosome segregation. Science (2003) 2.49
Cdc14 and condensin control the dissolution of cohesin-independent chromosome linkages at repeated DNA. Cell (2004) 2.44
Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev (2011) 2.29
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A (2013) 2.21
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci U S A (2009) 2.11
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Meiosis I is established through division-specific translational control of a cyclin. Cell (2008) 2.06
Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol Cell (2013) 2.05
Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest (2007) 2.05
Measurement of mass, density, and volume during the cell cycle of yeast. Proc Natl Acad Sci U S A (2009) 2.04
Kinetochore orientation during meiosis is controlled by Aurora B and the monopolin complex. Cell (2007) 2.00
Inhibition of homologous recombination by a cohesin-associated clamp complex recruited to the rDNA recombination enhancer. Genes Dev (2006) 1.98
At the interface between signaling and executing anaphase--Cdc14 and the FEAR network. Genes Dev (2004) 1.96
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev (2010) 1.95
Checking your breaks: surveillance mechanisms of meiotic recombination. Curr Biol (2006) 1.94
DNA sequence and analysis of human chromosome 8. Nature (2006) 1.91
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. Proc Natl Acad Sci U S A (2005) 1.88
A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc Natl Acad Sci U S A (2003) 1.84
The rate of cell growth is governed by cell cycle stage. Genes Dev (2009) 1.82
DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature (2006) 1.81
Gene copy-number alterations: a cost-benefit analysis. Cell (2013) 1.79
Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens (2005) 1.77
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A (2006) 1.73
Transcriptional consequences of aneuploidy. Proc Natl Acad Sci U S A (2012) 1.70
The FK506 binding protein Fpr3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity. Cell (2005) 1.68
Gametogenesis eliminates age-induced cellular damage and resets life span in yeast. Science (2011) 1.67
The protein kinase Kin4 inhibits exit from mitosis in response to spindle position defects. Mol Cell (2005) 1.67
Rec8 phosphorylation and recombination promote the step-wise loss of cohesins in meiosis. Nature (2006) 1.66
Aneuploidy causes proteotoxic stress in yeast. Genes Dev (2012) 1.66
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci U S A (2005) 1.65
Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol (2009) 1.64
Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A (2008) 1.63
Transcription of two long noncoding RNAs mediates mating-type control of gametogenesis in budding yeast. Cell (2012) 1.61
The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet (2011) 1.60
The Cdc14 phosphatase and the FEAR network control meiotic spindle disassembly and chromosome segregation. Dev Cell (2003) 1.58
Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep (2012) 1.51
Analysis of the DNA sequence and duplication history of human chromosome 15. Nature (2006) 1.50
Changes in cell morphology are coordinated with cell growth through the TORC1 pathway. Curr Biol (2013) 1.50
The monopolin complex crosslinks kinetochore components to regulate chromosome-microtubule attachments. Cell (2010) 1.48
Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development. Development (2010) 1.42
New insights into the troubles of aneuploidy. Annu Rev Cell Dev Biol (2012) 1.36
Genome complexity reduction for SNP genotyping analysis. Proc Natl Acad Sci U S A (2002) 1.32
The core centromere and Sgo1 establish a 50-kb cohesin-protected domain around centromeres during meiosis I. Genes Dev (2005) 1.30
A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse. Proc Natl Acad Sci U S A (2007) 1.30
The role of the polo kinase Cdc5 in controlling Cdc14 localization. Mol Biol Cell (2003) 1.30
Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A (2013) 1.28
APC/C-Cdh1-mediated degradation of the Polo kinase Cdc5 promotes the return of Cdc14 into the nucleolus. Genes Dev (2008) 1.26
The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet (2006) 1.26
A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat Genet (2002) 1.25
Control of meiosis by respiration. Curr Biol (2008) 1.25
The multiple roles of cohesin in meiotic chromosome morphogenesis and pairing. Mol Biol Cell (2008) 1.24
Control of Lte1 localization by cell polarity determinants and Cdc14. Curr Biol (2002) 1.23
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer (2014) 1.23
Genomic predictors of interindividual differences in response to DNA damaging agents. Genes Dev (2008) 1.20
The protein phosphatase 2A functions in the spindle position checkpoint by regulating the checkpoint kinase Kin4. Genes Dev (2009) 1.20
Cell polarity determinants establish asymmetry in MEN signaling. Dev Cell (2009) 1.20
The replication fork block protein Fob1 functions as a negative regulator of the FEAR network. Curr Biol (2004) 1.19
Novel response to microtubule perturbation in meiosis. Mol Cell Biol (2005) 1.17
Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab (2005) 1.17
Aneuploidy: cancer's fatal flaw? Cancer Res (2009) 1.16
Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol Biol Cell (2013) 1.16
Mitotic CDKs control the metaphase-anaphase transition and trigger spindle elongation. Genes Dev (2008) 1.16
Spo13 maintains centromeric cohesion and kinetochore coorientation during meiosis I. Curr Biol (2004) 1.16
Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci U S A (2007) 1.16
Emerging roles for centromeres in meiosis I chromosome segregation. Nat Rev Genet (2008) 1.14
Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis (2005) 1.13
The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell (2002) 1.13
The stress-activated mitogen-activated protein kinase signaling cascade promotes exit from mitosis. Mol Biol Cell (2006) 1.12
Regulation of Spo12 phosphorylation and its essential role in the FEAR network. Curr Biol (2009) 1.12
The FEAR network. Curr Biol (2009) 1.11
Regulation of entry into gametogenesis. Philos Trans R Soc Lond B Biol Sci (2011) 1.10
Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA. Proc Natl Acad Sci U S A (2006) 1.10
Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40phox in activation of the neutrophil NADPH oxidase. J Biol Chem (2007) 1.09
Meiosis I chromosome segregation is established through regulation of microtubule-kinetochore interactions. Elife (2012) 1.08
Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. Genet Epidemiol (2008) 1.06
Shugoshin promotes sister kinetochore biorientation in Saccharomyces cerevisiae. Mol Biol Cell (2007) 1.06
Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Nat Genet (2005) 1.05
DNA sequence and analysis of human chromosome 18. Nature (2005) 1.05